Biophytis - LIVE HEALTHIER LONGER

📍 Paris, France🗓 Founded 2006👥 25 employees💰 Last funded Jun 2013
Biotechnology🌐 biophytis.com
Website LinkedIn
Biophytis SA (www.biophytis.com), founded in 2006, develops drug candidates targeting diseases of aging. Using its technology and know-how, Biophytis has begun clinical development of innovative therapeutics to restore the muscular and visual functions in diseases with significant unmet medical needs. Specifically, the company is advancing two proprietary drug candidates into mid-stage clinical testing this year: Sarconeos (BIO101) to treat sarcopenic obesity and Macuneos (BIO201) to treat dry age-related macular degeneration (AMD). The business model of BIOPHYTIS is to ensure the conduct of the project until clinical activity in the patient is proven, then to license the technologies in order to continue the development in partnership with a pharmaceutical laboratory. The company was founded in partnership with researchers at the UPMC (Pierre and Marie Curie University) and collaborates with scientists at the Institute of Myology, and the Vision Institute
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2006
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Biophytis - LIVE HEALTHIER LONGER?
Biophytis - LIVE HEALTHIER LONGER has 1 investors on record on gritt.io and 1 late-stage investors.
When did Biophytis - LIVE HEALTHIER LONGER last raise funding?
The most recent investment in Biophytis - LIVE HEALTHIER LONGER recorded on gritt.io was in June 2013.
When was Biophytis - LIVE HEALTHIER LONGER founded?
Biophytis - LIVE HEALTHIER LONGER was founded in 2006.
What industry is Biophytis - LIVE HEALTHIER LONGER in?
Biophytis - LIVE HEALTHIER LONGER operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Biophytis - LIVE HEALTHIER LONGER based?
Biophytis - LIVE HEALTHIER LONGER is headquartered in Paris, France.